Literature DB >> 4056782

Developmental correlates of age at first hospitalization in nonschizophrenic psychiatric patients.

M Glick, E Zigler, B Zigler.   

Abstract

Age at first hospitalization, premorbid social competence, and developmental categorizations of symptomatology were examined in 228 male and 220 female patients in three diagnostic categories: major affective disorder, neuroses, and personality disorder. High social competence patients were older at first hospitalization than low competence individuals. Younger first admission patients showed more symptoms in the action category and in the role orientation of turning against others. Older patients more frequently displayed symptoms of the thought variety and of turning against the self. Gender differences in age at first hospitalization were not found. With respect to all developmental variables examined, the results suggest that a broader view of prognosis proposed in research with schizophrenic patients is applicable to nonschizophrenic groups.

Entities:  

Mesh:

Year:  1985        PMID: 4056782     DOI: 10.1097/00005053-198511000-00005

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  3 in total

1.  Which measure of adolescent psychiatric disorder--diagnosis, number of symptoms, or adaptive functioning--best predicts adverse young adult outcomes?

Authors:  A Vander Stoep; N S Weiss; B McKnight; S A A Beresford; P Cohen
Journal:  J Epidemiol Community Health       Date:  2002-01       Impact factor: 3.710

2.  Attentional-shaping as a means to improve emotion perception deficits in schizophrenia.

Authors:  Dennis R Combs; Aneta Tosheva; David L Penn; Michael R Basso; Jill L Wanner; Kristen Laib
Journal:  Schizophr Res       Date:  2008-06-27       Impact factor: 4.939

3.  Locus of control: relation to schizophrenia, to recovery, and to depression and psychosis -- A 15-year longitudinal study.

Authors:  Martin Harrow; Barry G Hansford; Ellen B Astrachan-Fletcher
Journal:  Psychiatry Res       Date:  2009-07-01       Impact factor: 3.222

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.